Jupiter Neurosciences, Inc.
JUNS
$1.65
$0.4638.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 132.19% | 118.72% | |||
| Gross Profit | -132.19% | -118.72% | |||
| SG&A Expenses | -14.80% | 213.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.46% | 195.52% | |||
| Operating Income | -5.46% | -195.52% | |||
| Income Before Tax | -0.09% | -158.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.09% | -158.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.09% | -158.48% | |||
| EBIT | -5.46% | -195.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 4.35% | -154.21% | |||
| Normalized Basic EPS | -2.12% | -137.82% | |||
| EPS Diluted | 4.35% | -141.50% | |||
| Normalized Diluted EPS | -2.12% | -137.82% | |||
| Average Basic Shares Outstanding | 4.62% | 1.86% | |||
| Average Diluted Shares Outstanding | 4.62% | 1.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||